Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Alexza CRL Followed 483 Citing Drug Storage, Training Lapses

  • Post author:Sam
  • Post published:April 8, 2016
  • Post category:QMN Weekly Bulletin

Concerns about inadequate drug storage and quality training at Alexza’s Mountain View, Calif., facility were cited by FDA investigators just weeks before the company received a complete response letter (CRL)…

Continue ReadingAlexza CRL Followed 483 Citing Drug Storage, Training Lapses

Branan Medical Gets Closeout Resolving Clearance Concerns

  • Post author:Sam
  • Post published:April 8, 2016
  • Post category:QMN Weekly Bulletin

Branan Medical, a maker of drug testing kits, received an FDA closeout letter resolving myriad marketing clearance and manufacturing concerns cited in a 2009 warning letter.

Continue ReadingBranan Medical Gets Closeout Resolving Clearance Concerns

Contamination Crackdown Forces Some Chinese Drugmakers to Halt Production

  • Post author:Sam
  • Post published:April 8, 2016
  • Post category:QMN Weekly Bulletin

Several drugmakers in China are being ordered to power down production lines and hand over their licenses for producing capsule-based drugs after a crackdown on chromium contamination by the country’s…

Continue ReadingContamination Crackdown Forces Some Chinese Drugmakers to Halt Production

Indianapolis Helmet Maker Warned on Records, Procedural Flaws

  • Post author:Sam
  • Post published:April 8, 2016
  • Post category:QMN Weekly Bulletin

The FDA has cited a manufacturer of cranial remodeling helmets on seven areas of documentation and policy flaws.

Continue ReadingIndianapolis Helmet Maker Warned on Records, Procedural Flaws

EMA Chided Over Lack of Transparency in Pediatric Trials Waiver Process

  • Post author:Sam
  • Post published:April 8, 2016
  • Post category:QMN Weekly Bulletin

The EU Ombudsman June 4 criticized the European Medicines Agency’s (EMA) lack of transparency and guidelines for deciding when to require drugmakers to carry out pediatric clinical trials.

Continue ReadingEMA Chided Over Lack of Transparency in Pediatric Trials Waiver Process

API Maker NuSil Warned for Quality, Contamination Concerns

  • Post author:Sam
  • Post published:April 8, 2016
  • Post category:QMN Weekly Bulletin

NuSil Technology, a California-based maker of active pharmaceutical ingredients (APIs) and industrial silicone products, has been warned for specification testing shortfalls and microbial contamination concerns related to its simethicone emulsion…

Continue ReadingAPI Maker NuSil Warned for Quality, Contamination Concerns

Prosec Protection Systems Handed 483 for Process Validation Lapses

  • Post author:Sam
  • Post published:April 7, 2016
  • Post category:QMN Weekly Bulletin

Prosec Protection Systems, a maker of umbilical clamps, received a Form 483 for various process validation deviations at its Lakewood, N.J., plant.

Continue ReadingProsec Protection Systems Handed 483 for Process Validation Lapses

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.